Interleukin-17A mediates cardiorenal injury in oxalate nephropathy
Cardiovascular Research · 2026
DOI: 10.1093/cvr/cvag158 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cardiovascular Research, 2026. Verfasst von Moritz I Wimmer und 24 weiteren Autor:innen. Beteiligte Einrichtung: Experimental and Clinical Research Center (ECRC), a cooperation of Charité - Universitätsmedizin Berlin and Max Delbrück Center for Molecular Medicin…. Hauptthemen laut MEDLINE: Interleukin-17, Th17 Cells, Kidney, Hyperoxaluria. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 68 Literaturangaben. Gefördert von: German Federal Ministry of Education and Research, FACSMelody, German Federal Ministry.
Abstract (Originalsprache)
Aims
Cardiovascular disease (CVD) is the leading cause of mortality in chronic kidney disease (CKD). While CKD is known to give rise to systemic inflammation, its inciting factors remain poorly defined. Oxalate, long implicated in rare genetic kidney disorders, accumulates with decreased kidney function and has emerged as a driver of inflammation and independent risk factor for CVD. Here, we investigate the immunological mechanisms linking oxalate nephropathy to systemic inflammation, cardiac damage and kidney injury. Methods and results Oxalate nephropathy was induced in C57BL6/N mice through an oxalate-enriched diet. Oxalate induced systemic immune activation, renal fibrosis, and adverse cardiac remodelling, including pulmonary congestion with systolic and diastolic dysfunction. Flow cytometry analysis identified interleukin (IL)-17A as a dominant inflammatory effector, with expansion of Th17 and Th17-like Treg in the kidney, intestine, and spleen. Bulk mRNA sequencing confirmed these findings in kidney and heart. In line, plasma IL-17A was increased in oxalate-fed mice. Confirming the oxalate-IL-17A relationship, plasma IL-17A was elevated in patients with primary hyperoxaluria. Gut microbiome analysis by 16S amplicon sequencing showed only mild oxalate-induced alterations in mice. However, soluble oxalate directly enhanced Th17 polarization and disrupted mitochondrial respiration in vitro. In vivo, antibody-mediated IL-17A blockade improved kidney function, cardiac fibrosis, reduced neutrophil infiltration, and partially restored cardiac function in oxalate-fed mice.
Conclusion
Our study identifies oxalate as a systemic immunometabolic stressor and IL-17A as a central mediator of oxalate-induced cardiorenal injury. These findings establish the oxalate-IL-17A axis as a mechanistic link between CKD and CVD and suggest IL-17A inhibition as a potential therapeutic strategy to reduce cardiovascular damage in CKD.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Experimental and Clinical Research Center (ECRC), a cooperation of Charité - Universitätsmedizin Berlin and Max Delbrück Center for Molecular Medicine, Berlin, Germany.
- Max-Delbrück-Center for Molecular Medicine in the Helmholtz Association, Berlin, Germany.
- DZHK (German Centre for Cardiovascular Research), partner site Berlin, Berlin, Germany.
- Department of Nephrology and Medical Intensive Care, Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany.
- Max Rubner Center for Cardiovascular Metabolic Renal Research, Charité - Universitätsmedizin Berlin, Berlin, Germany.
- Department of Microbial Immune Regulation, Helmholtz Center for Infection Research, Braunschweig, Germany.
ORCID-Profile: Moritz I Wimmer, Martin Reichel, Arne Thiele, Alex Yarritu, Ariana Matz-Rauch, Harithaa Anandakumar, Luisa Hernández Götz, Till R Lesker, Olena Potapenko, Natnael Gebremedhin, Wibke Anders, Sarah V Liévano Contreras, Rongling Wang, Felix Behrens, Bernd Hoppe, Olivia Nonn, Gabriele G Schiattarella, Franz Schaefer, Johannes Holle, Till Strowig, Alma Zernecke, Kai-Uwe Eckardt, Felix Knauf, Nicola Wilck, Hendrik Bartolomaeus
Förderung
- German Federal Ministry of Education and Research
- FACSMelody
- German Federal Ministry
- of Research, Technology and Space
- BMFTR
- TAhRget consortium
- QEED consortium
- German Research Foundation
Zitieren
APA
Wimmer, M. I., Reichel, M., Thiele, A., Yarritu, A., Matz-Rauch, A., Anandakumar, H., Hernández Götz, L., Lesker, T. R., Potapenko, O., Gebremedhin, N., Anders, W., Liévano Contreras, S. V., Wang, R., Behrens, F., Hoppe, B., Nonn, O., Schiattarella, G. G., Schaefer, F., Holle, J., …, & Bartolomaeus, H. (2026). Interleukin-17A mediates cardiorenal injury in oxalate nephropathy. Cardiovascular Research. https://doi.org/10.1093/cvr/cvag158
Vancouver
Wimmer MI, Reichel M, Thiele A, Yarritu A, Matz-Rauch A, Anandakumar H, et al. Interleukin-17A mediates cardiorenal injury in oxalate nephropathy. Cardiovascular Research. 2026. doi:10.1093/cvr/cvag158
BibTeX
@article{Wimmer2026,
author = {Wimmer, Moritz I and Reichel, Martin and Thiele, Arne and Yarritu, Alex and Matz-Rauch, Ariana and Anandakumar, Harithaa and Hernández Götz, Luisa and Lesker, Till R and Potapenko, Olena and Gebremedhin, Natnael and Anders, Wibke and Liévano Contreras, Sarah V and Wang, Rongling and Behrens, Felix and Hoppe, Bernd and Nonn, Olivia and Schiattarella, Gabriele G and Schaefer, Franz and Holle, Johannes and Strowig, Till and Zernecke, Alma and Eckardt, Kai-Uwe and Knauf, Felix and Wilck, Nicola and Bartolomaeus, Hendrik},
title = {Interleukin-17A mediates cardiorenal injury in oxalate nephropathy},
journal = {Cardiovascular Research},
year = {2026},
doi = {10.1093/cvr/cvag158}
}
EUVIMED